Your browser doesn't support javascript.
loading
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Connell, Nathan T; Flood, Veronica H; Brignardello-Petersen, Romina; Abdul-Kadir, Rezan; Arapshian, Alice; Couper, Susie; Grow, Jean M; Kouides, Peter; Laffan, Michael; Lavin, Michelle; Leebeek, Frank W G; O'Brien, Sarah H; Ozelo, Margareth C; Tosetto, Alberto; Weyand, Angela C; James, Paula D; Kalot, Mohamad A; Husainat, Nedaa; Mustafa, Reem A.
Affiliation
  • Connell NT; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Flood VH; Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI.
  • Brignardello-Petersen R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
  • Abdul-Kadir R; Department of Obstetrics and Gynaecology and Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Foundation Hospital and Institute for Women's Health, University College London, London, United Kingdom.
  • Arapshian A; Middle Village, NY.
  • Couper S; Maylands, WA, Australia.
  • Grow JM; Department of Strategic Communication, Marquette University, Milwaukee, WI.
  • Kouides P; Mary M. Gooley Hemophilia Treatment Center, University of Rochester, Rochester, NY.
  • Laffan M; Centre for Haematology, Imperial College London, London, United Kingdom.
  • Lavin M; Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland and National Coagulation Centre, St James's Hospital, Dublin, Ireland.
  • Leebeek FWG; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • O'Brien SH; Division of Hematology/Oncology, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH.
  • Ozelo MC; Hemocentro UNICAMP, University of Campinas, Campinas, Brazil.
  • Tosetto A; Hemophilia and Thrombosis Center, Hematology Department, S. Bortolo Hospital, Vicenza, Italy.
  • Weyand AC; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI.
  • James PD; Department of Medicine, Queen's University, Kingston, ON, Canada; and.
  • Kalot MA; Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.
  • Husainat N; Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.
  • Mustafa RA; Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.
Blood Adv ; 5(1): 301-325, 2021 01 12.
Article in En | MEDLINE | ID: mdl-33570647
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Von Willebrand Diseases / Venous Thromboembolism / Hemophilia A Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Marruecos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Von Willebrand Diseases / Venous Thromboembolism / Hemophilia A Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Marruecos Country of publication: Estados Unidos